Literature DB >> 7715928

Proliferative vitreoretinopathy in Coats' disease. Clinicohistopathological case report.

T Kubota1, K Kurihara, T Ishibashi, H Inomata.   

Abstract

We report the clinicohistopathological findings of the proliferative vitreoretinopathy in an eye with Coats' disease using the tissue obtained during surgery. A 28-year-old man, who had experienced poor vision in his right eye for a period of 4 years, was referred to our hospital. Examination revealed an extensive yellow exudate in the subretinal space and a tractional retinal detachment. Prominent teleangiectatic retinal vessels were also temporally present. Evident epiretinal membranes were present in the postequatorial area. We performed a scleral buckling, vitrectomy, membrane peeling, endophotocoagulation and silicone oil tamponade. A histological examination revealed that the epiretinal membrane consisted of collagen fibers, glial proliferation, foam cells and lymphocytes. The foam cell in the epiretinal membrane is a characteristic finding in an eye with Coats' disease.

Entities:  

Mesh:

Year:  1995        PMID: 7715928     DOI: 10.1159/000310576

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  3 in total

1.  Anterior proliferative vitreoretinopathy in a patient with Coats disease.

Authors:  Satoru Kase; Shohei Mori; Kousuke Noda; Susumu Ishida
Journal:  Int J Ophthalmol       Date:  2018-02-18       Impact factor: 1.779

2.  The effect of intravitreal bevacizumab injection as the initial treatment for Coats' disease.

Authors:  Xiao-Xue Zheng; Yan-Rong Jiang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-07-20       Impact factor: 3.117

3.  Surgical treatments for fibrous tissue extending to the posterior retina in eyes with familial exudative vitreoretinopathy.

Authors:  Mari Takahashi; Tadashi Yokoi; Satoshi Katagiri; Tomoyo Yoshida-Uemura; Sachiko Nishina; Noriyuki Azuma
Journal:  Jpn J Ophthalmol       Date:  2017-11-03       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.